Patient information: overview
Genostics® partners with the highly esteemed Maintrac® Laboratory (Germany) and is proud to be bringing the future of personalised cancer testing to Australia and New Zealand. Maintrac® is a state-of-the-art German technology that detects, characterises and tests CTCs. It has been critically validated and published in peer reviewed journals for over 12 years. Maintrac® CTC tests are acknowledged and utilised by many universities, Oncologists and cancer clinics worldwide.
Please speak with your treating practitioner in regards to your eligibility for a Genostics® test. Genostics® tests can only be requested by a certified, registered healthcare practitioner. The Medical Advice Disclaimer (below, see footer) applies to all Genostics® online and printed material. Genostics® tests are not covered by Medicare.